Tags:3DBioTechDeliveryDevelopmentDrugIndustryMedtechPrintingProductionTechnology
Laxxon Medical is a disruptive biotech startup whose 3-D printing technology is transforming the pharmaceutical industry. Laxxon Medical owns the exclusive rights to the development, production and commercialization of innovative drug delivery systems on the basis of a worldwide patented large-scale 3D screen printing.
Location: United States, New York
Member count: 11-50
Founded date: 2017

Investors 1

DateNameWebsite
-bm-t betei...bm-t.de

Mentions in press and media 1

DateTitleDescriptionCategoryAuthorSource
-Settlement...Laxxon optimises drug delivery...--bm-t.de/en...